Summary:
«TrialSpark, a health tech platform that lets providers become clinical trial sites, scored a whopping $156 million as part of a Series C funding round to start developing its own molecular treatments.»
Article written by Laura Lovett. Photo by franckreporter/Getty Images.
01|10|2021
Source:
Mobi Health News
https://www.mobihealthnews.com/news/tech-driven-clinical-trial-startup-trialspark-lands-156m-series-c